1Adsay V, Conlon K, Brennan MF, et al. Intraductal papillary mucinous neoplasms: a clinicopathologic study of in-situ and invasive carcinomas associated with 28 cases[J]. Cancer, 2002,94:62～77.
2Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas[J]. Am J Surg Pathol, 2004 ,28(7):839～848.
3Yamasaki H, Ikeda S, Okajima M, et al. Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors[J]. Int J Oncol, 2004 ,24(1):107～113.
4N Volkan Adsay, Kambiz Merati, Aleodor Andea, et al. The Dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis[J].Modern Pathol, 2002,15(10):1087～1095.
5Lan M S, Batra S K, Qi W N, et al. Cloning and sequencing of a human pancreatic tumor mucin cDNA [J].J Biol Chem, 1990,265: 15294-15299.
6Hamanaka Y, Suehiro Y, Fukui M, et al.Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer[J]. Int J Cancer, 2003,103(1):97～100.
7von Mensdorff - Pouilly S , Snijdewint FG , Verstraeten AA , et a l. Human MUC1 mucin : a multifaceted glycoprotein [J]. IntJ Biol Markers , 2000 , 15(4): 343～356 .
